课题基金 / 基金详情

Modulation of NK cell activity by dietary product for prostate cancer prevention

Modulation of NK cell activity by dietary product for prostate cancer prevention
通过膳食产品调节 NK 细胞活性预防前列腺癌
批准号:
8848506
负责人:
Dev Karan
金额:
$9.71万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-09 至 2016-05-31

项目摘要

项目成果

Dev Karan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Prostate cancer is a significant health problem and the second leading cause of cancer death among men in the United States with an estimated 30,000 deaths every year. The long-term goal of this research project is to develop a safe and effective strategy for prostate cancer prevention. While screening for the activity to stimulate immune cell function by dietary agents using an immune-competent mouse model for prostate cancer, we observed that the dietary agent withaferin-A (WA) significantly induced the activation of natural killer (NK) cells. The dietary agent, withaferin-A is a non-toxic, bioactive compound derived from the plant Withania somnifera, and is traditional medicine widely used in Asia and Africa to boost the immune system. However, the mechanism(s) regulating the functional activation of immune cells by the dietary agents WA remain largely unknown. Based on our preliminary observations, we hypothesize that the dietary agent WA augments NK cell function to inhibit the growth of prostate cancer cells. The rationale for our hypothesis is based on preliminary in vitro studies with WA and on epidemiologic studies indicating that dietary products help to maintain a healthy immune system. Recent studies provide genetic evidence for surveillance of primary tumors by NK cells in the TRAMP (transgenic adenocarcinoma of the mouse prostate), a useful model of prostate cancer. To test our hypothesis, we propose the following specific aims: 1) To determine the mechanism of functional activation of NK cells by WA; and 2) To characterize the mechanism of WA-induced tumoricidal activity by NK cells. The overall objective of this application is to systematically probe into these questions using prostat cancer as a disease model. We have found that the dietary agent WA is able to enhance the functional activity of NK cells. This project will provide a novel paradigm with high impact in the field of prostate cancer prevention given the paucity of information in the literature on the effec of dietary agents such as WA on the tumoricidal activity of NK cells in a prostate cancer model. Successful accomplishment of these studies will provide a rationale for future translational applications using WA to stimulate anticancer properties of NK immune cells for the prevention or delaying of prostate cancer.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41598-017-04286-4
发表时间: 2017-06-29
期刊: Scientific reports
影响因子: 4.6
作者: [Karan D, Tawfik O, Dubey S]
通讯作者: Dubey S
Modulation of host intrinsic immunity to reduce prostate cancer disparity
Modulation of host intrinsic immunity to reduce prostate cancer disparity
Modulation of host intrinsic immunity to reduce prostate cancer disparity
  • 批准号:
    10246377
  • 项目类别:
  • 资助金额:
    $30.79万
  • 财政年份:
    2016
  • 负责人:
    Dev Karan
  • 依托单位:
Racial disparity of MIC-1 gene in prostate tumor biology
国内基金
海外基金
基于多组学与可视化免疫动态成像技术解析EZH2抑制对增强CAR-NK细胞抗AML效应的机制研究
  • 批准号:
    JCZRLH202600775
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
腺苷经嘌呤补救途径代谢促进NK细胞免疫抑制的机制研究
  • 批准号:
    2026JJ60615
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    田宇茜
  • 依托单位:
记忆性NK细胞在肿瘤微环境中的跨物种代谢动态图谱研究
  • 批准号:
    2026JJ50431
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    熊佩文
  • 依托单位:
抑制IGSF8解除围术期氯胺酮对NK细胞抑制增强肝癌抗肿瘤免疫效应的机制研究
  • 批准号:
    JCZRLH202600798
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: